Skip to content

13F-HR filed by Antara Capital LP

Antara Capital LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 26 holding rows worth $215,724,000.

Accession
0001750183-19-000008
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 26 entries on the cover page, a total value of $215,724,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $215,714,000 with VALUE read as thousands by filing date, 13F file number 028-19352. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
THERAVANCE INC88338TAB0CORPORATE OBLIG49,388,000$46,609,000thousands by filing dateprincipal
CAESARS ENTMT CORP127686AA1NOTE27,000,000$45,921,000thousands by filing dateprincipal
TILRAY INCU8961EAA4DEBT 5.00010/025,750,000$17,075,000thousands by filing dateprincipal
BIOHAVEN PHARMACTL HLDG CO LG11196905CALL364,700$15,215,000thousands by filing datecall
INTELSAT S AL5140P951PUT540,100$12,314,000thousands by filing dateput
AVAYA HLDGS CORP05351XAB7NOTE 2.250% 6/113,460,000$11,531,000thousands by filing dateprincipal
HIGHLAND OPPS & INCOME FD43010E404HIGHLAND INCOME655,593$8,752,000thousands by filing date
Eldorado Resorts Inc28470R952COM210,400$8,388,000thousands by filing dateput
INTERCEPT PHARMACEUTICALS IN45845PAA6NOTE 3.250% 7/07,500,000$6,487,000thousands by filing dateprincipal
INNOVIVA INC45781M901CALL555,000$5,849,000thousands by filing datecall
CLOVIS ONCOLOGY INC189464950PUT1,250,000$4,912,000thousands by filing dateput
HILTON GRAND VACATIONS INC COM43283X105Stock150,000$4,800,000thousands by filing date
CONYERS PK II ACQUISITION CO212896203UNIT 99/99/9999400,000$4,252,000thousands by filing date
INNOVIVA INC45781M101COM378,861$3,993,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P958COM42,500$2,820,000thousands by filing dateput
OAKTREE ACQUISITION CORPG67145121UNIT 99/99/9999250,000$2,540,000thousands by filing date
TILRAY BRANDS INC88688T950COM100,000$2,474,000thousands by filing dateput
CLOVIS ONCOLOGY INC189464900CALL525,000$2,063,000thousands by filing datecall
ICPT 2 05 15 26 2 00000045845PAB4CONV BD US2,000,000$1,807,000thousands by filing dateprincipal
VanEck Vectors High Incom92189F908CALL150,000$1,762,000thousands by filing datecall
AVAYA HLDGS CORP05351X901CALL150,100$1,535,000thousands by filing datecall
CHICO'S FAS INC168615902COM304,100$1,225,000thousands by filing datecall
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM25,000$1,043,000thousands by filing date
TILRAY BRANDS INC88688T900Option40,100$992,000thousands by filing datecall
GARRETT MOTION INC35906A906COM892,400$773,000thousands by filing datecall
IMMUCELL CORP452525306COM PAR105,000$582,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001750183-19-000008this filing2019-11-14acceptance time not in the bulk data set